Video

Dr. Foley Discusses Guidelines for Cancer Pain Management

Dr. Kathleen Foley, from Memorial Sloan-Kettering Cancer Center, Discusses the World Health Organization Guidelines for Cancer Pain Management.

Kathleen M. Foley, MD, an Attending Neurologist in the Pain & Palliative Care Service at Memorial Sloan-Kettering Cancer Center, believes that one of the most important advances in the quality of care provided to patients with cancer pain were the guidelines developed by the World Health Organization (WHO) in the 1980s.

Foley notes that these guidelines made an enormous difference in the way that cancer pain was managed, throughout the world. In general, the guidelines dealt with the use of pharmacologic agents, as the mainstay approach.

However, as time progressed, it became clear that managing pain in cancer patients didn’t just involve pharmaceuticals. This type of pain is more complex, Foley explains, and requires a larger team of individuals working together to improve pain for patients with cancer.

<<<

View more from the 2012 MASCC International Symposium

Related Videos
Benjamin P. Levy, MD, with Kristie Kahl and Andrew Svonavec
Binod Dhakal, MD
Jill Corre, PharmD, PhD
Saad Z. Usmani, MD, MBA, FACP, FASCO
Ashraf Z. Badros, MBCHB
Thierry Andre, MD, professor, medical oncology, Sorbonne Université; head, Medical Oncology Department, Saint Antoine Hospital
Sanjay Popat, BSc, MBBS, FRCP, PhD, consultant medical oncologist, The Royal Marsden Hospital; professor, thoracic oncology, the Institute of Cancer Research
Toni Choueiri, MD, director, Lank Center for Genitourinary Oncology, co-leader, kidney cancer program, Dana-Farber Cancer Institute; Jerome and Nancy Kohlberg Chair, professor, medicine, Harvard Medical School
Angeles A. Secord, MD, MHSc, professor, obstetrics and gynecology, Duke Cancer Institute, discusses findings from the phase 2 PICCOLO trial (NCT05041257) investigating mirvetuximab soravtansine-gynx (Elahere) in patients with recurrent, platinum-sensitive ovarian cancer with high folate receptor alpha (FRα) expression.
Nancy U. Lin, MD, associate chief, Division of Breast Oncology, Susan F. Smith Center for Women’s Cancers, director, Metastatic Breast Cancer Program, director, Program for Patients with Breast Cancer Brain Metastases, Dana-Farber Cancer Institute; professor, medicine, Harvard Medical School